Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …

Background Cardiac resynchronization therapy (CRT) with or without a defibrillator has a
positive effect on mortality and morbidity for patients with heart failure. However …

Aims The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

Aims Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular function,
and survival in patients with heart failure (HF) and wide QRS. The benefit of adding …

Aims Cardiac resynchronization therapy with (CRTD) or without (CRTP) defibrillator is
recommended in selected patient with systolic chronic heart failure and wide QRS. There is …

Objectives To assess the benefits and harms of cardiac resynchronization with (CRT-D) and
compared to an ICD alone, CRT without a defibrillator (CRT-P) compared with optimal …